← SynDRA
RAMELTEON
SynDRA canonical compound SYN0004660 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | MTNR1B |
| Mechanism of action | Melatonin receptor agonist |
| Indication | insomnia |
| Disease area | neurology/psychiatry |
All known targets
Mechanisms of action (all sources)
- Melatonin receptor agonist
- MTNR1A AGONIST
- MTNR1B AGONIST
- MTNR1A MODULATOR
- MTNR1B MODULATOR
Drug classes
- Melatonin Receptor Agonists
- Melatonin Receptor Agonist
ATC classes
- N05C · HYPNOTICS AND SEDATIVES
Cross-references
Synonyms
- rozerem
- TAK-375
- TAK375
- Rozerem
- Ramelteon [USAN]
- Rozerem (TN)
- Ramelteon (JAN/USAN/INN)
- Rozerem, TAK-375, Ramelteon
- N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide
- N-{2-[(8s)-1,6,7,8-tetrahydro-2h-indeno[5,4-b]fur-8-yl]ethyl}propanamid
- (-)-N-(2-(((8S)-1,6,7,8-Tetrahydro-2H-indeno(5,4-b)furan-8-yl)ethyl)propanamide
- (S)-N-(2-(1,6,7,8-tetrahydro-2H-indeno-(5,4)furan-8-yl)ethyl)propionamide
- ramelteonum
- RefChem:55966
- N05CH02
- DTXCID301508624
- MFCD08067736
- SMR002544684
- SR-05000001957
- s1259
- UNII-901AS54I69
- HSDB 7787
- Ramelteon [USAN:INN:BAN:JAN]
- JEV
- Ramelteon (Standard)
- Ramelteon Impurity 72
- RAMELTEON [INN]
- RAMELTEON [JAN]
- RAMELTEON [HSDB]
- RAMELTEON [VANDF]
- Ramelteon (TAK-375)
- RAMELTEON [MART.]
- RAMELTEON [WHO-DD]
- SCHEMBL29237
- BSPBio_002318
- MLS003915619
- MLS006010029
- TAK-375SL
Reported adverse events
- Nausea
- Dizziness
- Fatigue
- Somnolence
Look up RAMELTEON in the interactive SynDRA portal →